Daratumumab-Mediated Lysis of Primary Multiple Myeloma Cells Is Enhanced in Combination With the Human Anti-Kir Antibody IPH2102 and Lenalidomide
Haematologica - Italy
doi 10.3324/haematol.2014.117531
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 15, 2014
Authors
Publisher
Ferrata Storti Foundation (Haematologica)